ScholarIQanswers from OpenAlex

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

PaperCitations, authors & open-access status

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer have?

ScholarIQcitation count

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has 90 citations in the OpenAlex counts ScholarIQ stores.

When was Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer published?

ScholarIQyear

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

ScholarIQoa status

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer has closed oa status in the ScholarIQ index.

What is the DOI of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

ScholarIQdoi

The DOI for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

What is the PMID of Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

ScholarIQpmid

The PMID for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

What is the OpenAlex record for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer?

ScholarIQopenalex

The OpenAlex for Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial